Two Sigma Investments’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.35M | Buy |
137,015
+4,482
| +3% | +$122K | ﹤0.01% | 2091 |
|
|
2025
Q4 | $3.6M | Buy |
132,533
+59,132
| +81% | +$1.56M | 0.01% | 2001 |
|
|
2025
Q3 | $1.9M | Sell |
73,401
-7,332
| -9% | -$170K | ﹤0.01% | 2164 |
|
|
2025
Q2 | $1.64M | Buy |
80,733
+52,077
| +182% | +$1.01M | ﹤0.01% | 1960 |
|
|
2025
Q1 | $520K | Sell |
28,656
-4,369
| -13% | -$97.6K | ﹤0.01% | 2505 |
|
|
2024
Q4 | $835K | Buy |
+33,025
| New | +$897K | ﹤0.01% | 2290 |
|
|
2024
Q2 | – | Sell |
-151,391
| Closed | -$6.35M | – | 3069 |
|
|
2024
Q1 | $6.35M | Buy |
+151,391
| New | +$6.22M | 0.02% | 849 |
|
|
2023
Q3 | – | Sell |
-18,423
| Closed | -$625K | – | 2982 |
|
|
2023
Q2 | $625K | Sell |
18,423
-6,661
| -27% | -$224K | ﹤0.01% | 2222 |
|
|
2023
Q1 | $903K | Buy |
+25,084
| New | +$1.08M | ﹤0.01% | 1929 |
|
|
2022
Q4 | – | Sell |
-29,780
| Closed | -$837K | – | 2829 |
|
|
2022
Q3 | $837K | Sell |
29,780
-243,840
| -89% | -$7.48M | ﹤0.01% | 1546 |
|
|
2022
Q2 | $7.38M | Buy |
273,620
+44,672
| +20% | +$1.3M | 0.02% | 614 |
|
|
2022
Q1 | $7.8M | Buy |
228,948
+35,307
| +18% | +$1.13M | 0.02% | 705 |
|
|
2021
Q4 | $7.48M | Buy |
+193,641
| New | +$8.44M | 0.02% | 959 |
|
|
2021
Q1 | – | Sell |
-196,792
| Closed | -$3.45M | – | 3895 |
|
|
2020
Q4 | $3.45M | Sell |
196,792
-193,150
| -50% | -$3.48M | 0.01% | 1142 |
|
|
2020
Q3 | $5.78M | Buy |
389,942
+258,848
| +197% | +$3.03M | 0.02% | 737 |
|
|
2020
Q2 | $1.7M | Buy |
+131,094
| New | +$581K | 0.01% | 1182 |
|
|
2019
Q3 | – | Sell |
-34,308
| Closed | -$92K | – | 3523 |
|
|
2019
Q2 | $92K | Buy |
+34,308
| New | +$117K | ﹤0.01% | 3211 |
|
|
2019
Q1 | – | Sell |
-116,072
| Closed | -$345K | – | 3089 |
|
|
2018
Q4 | $345K | Buy |
116,072
+1,724
| +2% | +$8.47K | ﹤0.01% | 2362 |
|
|
2018
Q3 | $774K | Buy |
114,348
+24,241
| +27% | +$170K | ﹤0.01% | 2162 |
|
|
2018
Q2 | $681K | Buy |
+90,107
| New | +$1.2M | ﹤0.01% | 2431 |
|
|
2018
Q1 | – | Sell |
-18,791
| Closed | -$800K | – | 3209 |
|
|
2017
Q4 | $800K | Buy |
+18,791
| New | +$805K | ﹤0.01% | 2116 |
|
Other funds holding CLDX
KCM
VCM
CC
EP